ACT PSM Abstract Presentations 3

Saturday, March 12, 2022

11:10 AM – 12:00 PM CST

Location:Coronado

Moderator(s)

Oliver Eng, MD

Associate Professor of Surgery
University of California, Irvine, United States
Jonathan Greer, MD

Assistant Professor of Surgery and Oncology
Johns Hopkins University School of Medicine, MD, United States

Participants should be aware of the following financial/non-financial relationships:

Oliver Eng, MD: Aileron Therapeutics Inc (Individual(s) Involved: Self): Stockholder; Alpine Immune Sciences (Individual(s) Involved: Self): Stockholder; ALX Oncology Holdings Inc (Individual(s) Involved: Self): Stockholder; Arbutus Biopharma Corp (Individual(s) Involved: Self): Stockholder; ARK Funds (Individual(s) Involved: Self): Stockholder; Cerevel Therapeutics Holdings Inc (Individual(s) Involved: Self): Stockholder; Iovance Biotherapeutics (Individual(s) Involved: Self): Stockholder; Mediwound Ltd (Individual(s) Involved: Self): Stockholder; Novavax, Inc. (Individual(s) Involved: Self): Stockholder; Phathom Pharmaceuticals Inc (Individual(s) Involved: Self): Stockholder; Tarsus Pharmaceuticals Inc (Individual(s) Involved: Self): Stockholder; Veru Inc (Individual(s) Involved: Self): Stockholder; Zymeworks Inc (Individual(s) Involved: Self): Stockholder

Jonathan B. Greer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

11:10 AM – 11:11 AM CST

Introductions
11:11 AM – 11:19 AM CST

A27: Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study
Abstract Presenter: Kevin M. Turner, MD – University of Cincinnati
11:19 AM – 11:21 AM CST

A27: Q&A
Abstract Presenter: Kevin M. Turner, MD – University of Cincinnati
11:21 AM – 11:29 AM CST

A31: Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC
Abstract Presenter: Cecilia Ong, MD – University of Chicago
11:29 AM – 11:31 AM CST

A31: Q&A
Abstract Presenter: Cecilia Ong, MD – University of Chicago
11:31 AM – 11:39 AM CST

A39: Systemic Metastases from Low-grade and High-grade Pseudomyxoma Peritonei: Treatments and Outcomes
Abstract Presenter: Dario Baratti – Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Italy)
11:39 AM – 11:41 AM CST

A39: Q&A
Abstract Presenter: Dario Baratti – Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Italy)
11:41 AM – 11:49 AM CST

A26: Disparities in Care Access Among Medicare Beneficiaries with Appendiceal or Colorectal Cancer and Peritoneal Metastasis
Abstract Presenter: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
11:49 AM – 11:51 AM CST

A26: Q&A
Abstract Presenter: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
11:51 AM – 11:59 AM CST

A36: Rethinking Routine Intensive Care Following Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: The Fiscal Argument
Abstract Presenter: Patrick B. Schwartz, MD – University of Wisconsin, Madison
11:59 AM – 12:00 PM CST

A36: Q&A
Abstract Presenter: Patrick B. Schwartz, MD – University of Wisconsin, Madison